von Hippel-Lindau tumor suppressor protein represses platelet-derived growth factor B-chain gene expression via the Sp1 binding element in the proximal PDGF-B promoter
VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of certain genes that are overexpressed in renal carcinomas. One such gene is that encoding the potent mitogen and chemoattractant, platelet‐derived g...
Saved in:
Published in | Journal of cellular biochemistry Vol. 85; no. 3; pp. 490 - 495 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
New York
Wiley Subscription Services, Inc., A Wiley Company
2002
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | VHL is the causative gene for von Hippel‐Lindau disease and sporadic clear cell renal cancer. It has been shown that pVHL can suppress the expression of certain genes that are overexpressed in renal carcinomas. One such gene is that encoding the potent mitogen and chemoattractant, platelet‐derived growth factor B‐chain (PDGF‐B). The regulatory mechanisms underlying pVHL suppression of PDGF‐B expression, however, are completely unknown. This understanding would shed vital light on the control of growth factor gene expression by this tumor suppressor. Here we report that pVHL can repress both endogenous steady‐state PDGF‐B mRNA expression and PDGF‐B promoter‐dependent transcription in WKY12‐22 cells. Transient transfection analysis utilizing PDGF‐B promoter‐chloramphenicol acetyl transferase (CAT) reporter constructs revealed that pVHL inhibition of PDGF‐B expression is mediated via the Sp1‐binding element in the proximal region of the PDGF‐B promoter. Recent studies have demonstrated a physical interaction between pVHL and Sp1, which activates the PDGF‐B promoter. We show that Sp1 can rescue PDGF‐B promoter activity and endogenous PDGF‐B mRNA expression from pVHL repression. These findings thus demonstrate a pivotal role for Sp1 in pVHL inhibition of PDGF‐B transcription. J. Cell. Biochem. 85: 490–495, 2002. © 2002 Wiley‐Liss, Inc. |
---|---|
Bibliography: | National Health and Medical Research Council of Australia ark:/67375/WNG-X9R2F4CL-R istex:382F899DF40DBD4AB4B35EC270B3BF63BEE4784B ArticleID:JCB10152 NSW State Department of Health ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0730-2312 1097-4644 |
DOI: | 10.1002/jcb.10152 |